Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients

Lead Sponsor:

University of Michigan Rogel Cancer Center

Conditions:

Cancer

Quality of Life

Eligibility:

All Genders

5+ years

Phase:

NA

Brief Summary

This study will investigate the use of a mobile health app (Roadmap 2.0) intervention in caregivers of patients with cancer. In this study participants will be given the Roadmap 2.0 app, with a focus ...

Detailed Description

Health information technology tools may enable caregivers and patients to become more active participants in their healthcare.This study is not to provide any treatment, but rather to investigate the ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • The caregiver must have an eligible patient (defined in items 5 - 9, below)
  • The caregiver must be of age ≥18 years.
  • The caregiver should be comfortable in reading and speaking English and signing informed consents.
  • The caregiver should provide at least 50% of care needs.
  • An eligible patient is one who identifies the eligible caregiver as their primary caregiver (i.e., provides at least 50% of care needs). The caregiver who provides consent will be deemed the caregiver who participates in the study. In adolescents who are at the age to provide assent, she/he will designate the caregiver who provides \>50% of their care, and that caregiver will sign the consent document.
  • An eligible patient is age ≥5 years.
  • An eligible patient is able to sign informed consent/assent forms.
  • Patients and caregivers agree to provide informed consent that is in regulatory compliance and IRBMED-approved.
  • The caregiver and patient must have his/her own smartphone or tablet to participate.

Exclusion

    Key Trial Info

    Start Date :

    September 18 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 20 2023

    Estimated Enrollment :

    138 Patients enrolled

    Trial Details

    Trial ID

    NCT04480541

    Start Date

    September 18 2020

    End Date

    June 20 2023

    Last Update

    November 29 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, United States, 48109